ArticleRSC advances2026
Evaluation of novel multifunctional polymeric Schiff bases as anticorrosive agents for the medical grade 316L stainless steel.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the field of biomaterials, the 316L stainless steel (316L SS) alloy is utilized in several countries as a temporary biomaterial without any prior treatment. In this work, corrosion protection and biocompatibility enhancements of the 316L SS alloy were performed. The influence of recently synthesized novel antibacterial, antimicrobial, and antioxidant polymeric materials, as corrosion inhibitors, on the 316L stainless steel surface was investigated. Initially, the primary amino groups of casein were reacted with the active carbonyl group of cinnamaldehyde to yield casein-cinnamadehyde (Ca-Cin) Schiff bases. These Schiff bases were then allowed to interact with the 316L SS alloy, resulting in self-assembled monolayers (SAMs) covering its surface. The features of these SAMs were then evaluated under simulated body fluid (SBF) conditions by electrochemical methods. Results confirmed the formation of SAMs from the studied Schiff bases, serving as mixed-type inhibitors on the 316L SS surface
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.